[Federal Register Volume 74, Number 17 (Wednesday, January 28, 2009)]
[Notices]
[Page 4961]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-1737]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Committee on Heritable Disorders in Newborns and 
Children; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Public Law 92-463), notice is hereby given of the 
following meeting:
    Name: Advisory Committee on Heritable Disorders in Newborns and 
Children (ACHDNC).
    Dates and Times: February 26, 2009, 8:30 a.m. to 5 p.m. February 
27, 2009, 8:30 a.m. to 3 p.m.
    Place: Bethesda Marriott-Pooks Hill, 5151 Pooks Hill Road, 
Bethesda, MD 20814.
    Status: The meeting will be open to the public with attendance 
limited to space availability. Participants are asked to register for 
the meeting by going to the registration Web site at http://events.SignUp4.com/ACHDNC0209. The registration deadline is Wednesday, 
February 25, 2009. Individuals who need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
indicate their needs on the registration Web site. The deadline for 
special accommodation requests is Friday, February 20, 2009. If there 
are technical problems gaining access to the Web site, please contact 
Tamar R. Shealy, Meetings Manager, Conference and Meetings Management, 
Altarum Institute, by telephone (202) 828-5100 or via e-mail 
<a href="/cdn-cgi/l/email-protection#395a56575f5c4b5c575a5c4a7958554d584b4c5417564b5e"><span class="__cf_email__" data-cfemail="4a2925242c2f382f24292f390a2b263e2b383f276425382d">[email protected]</span></a>.
    Purpose: The ACHDNC was established to advise and guide the 
Secretary regarding the most appropriate application of universal 
newborn screening tests, technologies, policies, guidelines and 
programs for effectively reducing morbidity and mortality in newborns 
and children having or at risk for heritable disorders. The ACHDNC also 
provides advice and recommendations concerning the grants and projects 
authorized under the Newborn Screening Saves Lives Act 2008.
    Agenda: The meeting agenda will include presentations and continued 
discussions on the nomination/evaluation process for newborn screening 
candidate conditions. The agenda also includes an update on the 
American Health Information Community's Newborn Screening Use Case and 
presentations on the National Institutes of Health funded Translational 
Research Network, and associated research policies and practices, as 
well as presentations on the continued work and reports of the ACHDNC's 
subcommittees on laboratory standards and procedures, follow-up and 
treatment, and education and training.
    Proposed agenda items are subject to change as priorities dictate. 
You can locate the agenda, committee roster and charter, presentations, 
and meeting materials at the home page of the Web site at http://events.SignUp4.com/ACHDNC0209.
    Public Comments: Members of the public can present oral comments 
during the public comment period of the meeting. There will be two 
public comment periods during this meeting. Comments on Thursday, 
February 26, 2009, will relate to the Advisory Committee's discussion 
of adding Severe Combined Immunodeficiency (SCID) to the recommended 
uniform screening panel. Comments on Friday, February 27, 2009, will 
relate to all other Committee issues. Those individuals who want to 
make a comment are requested to register online by Wednesday, February 
25, 2009, at http://events.SignUp4.com/ACHDNC0209. Requests will 
contain the name, address, telephone number, and any professional or 
business affiliation of the person desiring to make an oral 
presentation. Groups having similar interests are requested to combine 
their comments and present them through a single representative. The 
list of public comment participants will be posted on the Web site. 
Written comments should be e-mailed no later than Wednesday, February 
25, 2009, for consideration. Comments should be submitted to Tamar R. 
Shealy, Meetings Manager, Conference and Meetings Management, Altarum 
Institute, 1200 18th Street, NW., Suite 700, Washington, DC 20036, 
telephone: 202-828-5100; fax: 202-785-3083, or e-mail: 
<a href="/cdn-cgi/l/email-protection#d9bab6b7bfbcabbcb7babcaa99b8b5adb8abacb4f7b6abbe"><span class="__cf_email__" data-cfemail="a1c2cecfc7c4d3c4cfc2c4d2e1c0cdd5c0d3d4cc8fced3c6">[email protected]</span></a>.
    Contact Person: Anyone interested in obtaining other relevant 
information should write or contact Alaina M. Harris, Maternal and 
Child Health Bureau, Health Resources and Services Administration, Room 
18A-19, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 
20857, Telephone (301) 443-0721, <a href="/cdn-cgi/l/email-protection#4e2f262f3c3c273d0e263c3d2f60292138"><span class="__cf_email__" data-cfemail="c9a8a1a8bbbba0ba89a1bbbaa8e7aea6bf">[email protected]</span></a>. More information on 
the Advisory Committee is available at http://mchb.hrsa.gov/heritabledisorderscommittee.

    Dated: January 21, 2009.
Alexandra Huttinger,
Director, Division of Policy Review and Coordination.
 [FR Doc. E9-1737 Filed 1-27-09; 8:45 am]
BILLING CODE 4165-15-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>